Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R. Barrett, Catherine Green, Pedro M. Folegatti et al.|Nature Medicine|2020Cited by 340
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenonJack Mellors, Miles W. Carroll|Cellular and Molecular Life Sciences|2024Cited by 11